Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Zymeworks Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results"
06/12/2023 8-A12B/A Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]
06/12/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Elimination of Series B Participating Preferred Stock of Zymeworks Inc",
"Certificate of Elimination of Series B Participating Preferred Stock of Zymeworks Inc"
05/18/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Separation Agreement and Release by and between Zymeworks BC Inc. and Neil Klompas",
"Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer"
05/16/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Amended and Restated License and Collaboration Agreement, by and between Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Limited"
05/08/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/08/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/08/2023 8-K Quarterly results
Docs: "Zymeworks Provides Corporate Update and Reports First Quarter 2023 Financial Results"
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/01/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/26/2023 8-K Quarterly results
04/18/2023 8-K Quarterly results
03/17/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/15/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Amended and Restated Bylaws of Zymeworks Inc",
"Amended and Restated Bylaws of Zymeworks Inc"
03/07/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/07/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/07/2023 10-K Annual Report for the period ended December 31, 2022
03/07/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
03/07/2023 8-K Quarterly results
Docs: "Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results"
02/14/2023 SC 13G/A BAKER BROS. ADVISORS LP reports a 5.9% stake in Zymeworks Inc.
02/14/2023 SC 13G/A EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Zymeworks Inc.
02/14/2023 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 7.2% stake in Zymeworks Inc.
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G MORGAN STANLEY reports a 8.9% stake in Zymeworks Inc.
02/02/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/19/2023 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
01/04/2023 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2023"
01/03/2023 SC 13G BIOTECHNOLOGY VALUE FUND L P reports a 9.3% stake in Zymeworks Inc.
12/30/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment to Employment Agreement, by and among Kenneth Galbraith, Zymeworks BC Inc. and Zymeworks Management Inc",
"Amendment to Employment Agreement, by and among Kenneth Galbraith, Zymeworks BC Inc. and Zymeworks Management Inc"
12/28/2022 SC 13D/A All Blue Falcons FZE reports a 4.4% stake in Zymeworks Inc.
12/21/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab"
12/19/2022 8-K Quarterly results
12/19/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy